UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.46 | -0.46 |
| Q1 2022 | 2022-05-10 | -0.36 | -0.36 |
| Q4 2021 | 2022-03-01 | -0.50 | -0.50 |
| Q3 2021 | 2021-11-09 | -0.29 | -0.29 |
| Q2 2021 | 2021-08-09 | -0.39 | -0.39 |
| Q1 2021 | 2021-05-10 | -0.27 | -0.27 |
| Q4 2020 | 2021-03-01 | -0.14 | -0.14 |
| Q3 2020 | 2020-11-09 | 0.11 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.83 | -0.83 |
| 2016-06-21 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-06-21 | Reiterated Rating | Rodman & Renshaw | Buy | $17.00 |
| 2016-06-21 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2016-05-17 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-05-09 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-09 | Reiterated Rating | Stifel Nicolaus | Buy | $13.00 |
| 2016-04-27 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-04-09 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-03-24 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-03-20 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-03-20 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2016-03-15 | Reiterated Rating | Stifel Nicolaus | Buy | $19.00 to $13.00 |
| 2016-03-15 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-03-14 | Lower Price Target | Brean Capital | Buy | $20.00 to $18.00 |
| 2016-02-21 | Reiterated Rating | Piper Jaffray | Overweight | $31.00 |
| 2016-02-21 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2016-02-21 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $31.00 |
| 2016-02-13 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-02-01 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2016-01-29 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-01-20 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-01-05 | Lower Price Target | Maxim Group | Buy | $23.00 to $14.00 |
| 2015-11-11 | Reiterated Rating | Stifel Nicolaus | Buy | $19.00 |
| 2015-09-22 | Reiterated Rating | Maxim Group | Buy | $23.00 |
| 2015-09-21 | Reiterated Rating | Piper Jaffray | Overweight | $31.00 |
| 2015-09-09 | Boost Price Target | Maxim Group | Buy | $20.00 to $23.00 |
| 2015-08-11 | Reiterated Rating | Brean Capital | Buy | $20.00 |
| 2015-08-11 | Reiterated Rating | Stifel Nicolaus | Buy | $19.00 |
| 2015-08-10 | Reiterated Rating | Piper Jaffray | Overweight | $31.00 |
| 2015-07-24 | Reiterated Rating | Maxim Group | Buy | $20.00 |
| 2015-05-12 | Reiterated Rating | Brean Capital | Buy | $20.00 |
| 2015-04-09 | Reiterated Rating | HC Wainwright | Buy | |
| 2015-03-12 | Initiated Coverage | HC Wainwright | Buy | $17.00 |
| 2015-01-06 | Set Price Target | Maxim Group | Buy | $20.00 |
| 2014-12-22 | Initiated Coverage | Maxim Group | Buy | $18.00 |
| 2014-07-24 | Upgrade | Aegis Capital | Hold to Buy | $10 to $19 |
| 2014-07-24 | Upgrade | Aegis | Hold to Buy | $10.00 to $19.00 |
| 2014-06-23 | Initiated Coverage | Aegis | Positive | |
| 2014-06-09 | Reiterated Rating | Aegis | Hold | |
| 2014-05-21 | Reiterated Rating | Aegis | Hold | |
| 2014-05-07 | Initiated Coverage | Stifel Nicolaus | Buy | $16.00 |
| 2014-03-18 | Boost Price Target | Maxim Group | Buy | $12.00 to $24.00 |
| 2014-03-10 | Boost Price Target | Piper Jaffray | $26.00 | |
| 2014-01-24 | Boost Price Target | Brean Capital | Buy | $12.00 to $16.00 |
| 2013-11-13 | Reiterated Rating | Aegis | Hold to Hold | $10.00 |
| 2013-08-16 | Downgrade | Aegis Capital | Buy to Hold | |
| 2013-07-09 | Reiterated | Maxim Group | Buy | $1 to $2 |
| 2013-03-11 | Initiated | Aegis Capital | Buy | $1.50 |
| 2010-08-03 | Initiated | Brean Murray | Buy | $2 |
| 2010-03-26 | Initiated | Roth Capital | Buy | $2.80 |
| 2008-11-26 | Reiterated | Rodman & Renshaw | Mkt Outperform | $2 to $1 |
| 2008-05-14 | Reiterated | Rodman & Renshaw | Mkt Outperform | $5 to $2 |
| 2007-10-09 | Reiterated | BWS Financial | Buy | $6 to $3.50 |
| 2007-04-25 | Initiated | Thomas Weisel | Overweight | $8 |
| 2007-02-27 | Initiated | BWS Financial | Buy | $6 |
| 2016-06-21 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-06-21 | Reiterated Rating | Rodman & Renshaw | Buy | $17.00 |
| 2016-06-21 | Reiterated Rating | HC Wainwright | Buy | $17.00 |
| 2016-05-17 | Reiterated Rating | Maxim Group | Buy | $14.00 |
| 2016-05-09 | Reiterated Rating | Maxim Group | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In INO 133 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| STATE STREET CORP | 26.03M |
| BlackRock Inc. | 21.54M |
| Vanguard Group, Inc | 15.38M |
| D. E. Shaw & Co., Inc. | 7.55M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.60M |
| JPMORGAN CHASE & CO | 3.30M |
| BlackRock Fund Advisors | 3.17M |
| Rafferty Asset Management, LLC | 2.36M |
| RENAISSANCE TECHNOLOGIES LLC | 2.32M |
| CITADEL ADVISORS LLC | 2.27M |
| TWO SIGMA ADVISERS, LLC | 2.26M |
| NORTHERN TRUST CORP | 2.18M |
| CITIGROUP INC | 2.01M |
| TWO SIGMA INVESTMENTS LLC | 1.90M |
| BlackRock Institutional Trust Company, N.A. | 1.84M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MARXE AUSTIN W & GREENHOUSE DAVID M | 6.49% (3919706) | ADEP / ALCS / ASTC / ASYS / BTUI / BWEN / CACH / CDTI / CEVA / CLRX / CRMB / CYCC / DAEG / DOVR / ERI / ETRM / HEAR / INO / ISNS / ITI / LRAD / LTBR / MAG / MFI / OPXA / OVRL / PFSW / PLUG / PRKR / PTN / RGDX / RVLT / TGEN / URRE / VPCO / WPCS / |
| Kim Jong Joseph Chief Executive Officer | 3.79% (2291807) | INO / |
| Weiner David B. | 1.26% (758956) | INO / |
| COLLINS MORTON | 0.25% (152291) | INO / KOPN / |
| Sardesai Niranjan Chief Operating Officer | 0.20% (123486) | INO / |
| KIES PETER CFO | 0.14% (82088) | INO / |
| Bagarazzi Mark Chief Medical Officer | 0.13% (81513) | INO / |
| DHILLON AVTAR S Executive Chairman | 0.12% (73333) | INO / ONCS / |
| Cabrera Angel | 0.09% (51750) | INO / PETM / |
| BENITO SIMON X | 0.05% (27798) | DRRX / INO / |
| MAHMOUD ADEL | 0.02% (15000) | BDX / GNVC / INO / |
| Wysenski Nancy | 0.01% (5000) | ALKS / INO / TTPH / |
| Bickerstaff George | 0.01% (4090) | ARIA / CDNA / INO / THRX / |
UM